Prognostic value of the dynamic hepatorenal function on intermediate-term mortality in TAVI patients with survival to discharge.
Yijun YaoJingjing HeTianyuan XiongFei ChenYuanweixiang OuYiming LiQi LiuZhongkai ZhuYi ZhangHaoran YangYujia LiangXin WeiXi LiYong PengJiafu WeiSen HeQiao LiYong ChenWei MengGuo ChenWenxia ZhouMingxia ZhengXuan ZhouMao ChenYuan FengPublished in: Clinical cardiology (2022)
High MELD-XI score at baseline is an independent predictor for 2-year mortality. Patients with hepatorenal function improvement after TAVI have better outcomes. For patients with irreversible hepatorenal dysfunction after TAVI, further optimization of the subsequent treatment after TAVI is needed to improve the outcomes.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- cardiovascular events
- ejection fraction
- risk factors
- oxidative stress
- left ventricular
- type diabetes
- cardiovascular disease
- metabolic syndrome
- replacement therapy
- adipose tissue
- insulin resistance
- free survival
- smoking cessation